Results 61 to 70 of about 32,807 (303)

Transdermal Administration of Bromocriptine.

Biological and Pharmaceutical Bulletin, 2003
Bromocriptine (BRC) has been mainly used for the inhibition of lactation, treatment of menstrual disorders, Parkinson disease, breast tumours, infertility and brain tumours as a dopamine agonist in clinics. But current BRC formulations have some side effects and bioavailability problems because of hepatic first pass effect.
Lortlar, ND, Degim, LT, Acarturk, FÜSUN, Erdogan, D   +3 more
openaire   +5 more sources

Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2015
In the article Gaziano et al, “Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects,” which published online October 12, 2012, and appeared in the October ...
L. Wilkins
semanticscholar   +1 more source

Dopamine and prolactin in migraine: Mechanisms and potential therapeutic targets

Journal of Neuroendocrinology, EarlyView.
Prolactin and dopamine modulate migraine‐relevant trigeminal pathways. Hyperprolactinemia is associated with migraine‐like headache, and preclinical studies show that prolactin enhances trigeminal excitability, particularly in females. Dopamine inhibits prolactin release and may also directly suppress trigeminovascular activity via D2 receptors in the ...
Astrid Johannesson Hjelholt, Randi Maria Hanghøj Tei, Hans Christoph Diener, Jens Otto Lunde Jørgensen   +3 more
wiley   +1 more source

Bromocriptine and insulin secretion

Bioscience Reports, 1982
The dopaminergic drug bromocriptine inhibited the release of insulin from isolated mouse pancreatic islets. The effect was counteracted by haloperidol or pimozide. It is suggested that insulin release may be inhibited through activation of D-2 dopaminergic receptors in the pancreatic beta-cells.
Eva Gagerman, Ezz-Eldin S. M. El-Denshary, Inge-Bert Täljedal, Nabila A. Ismail, Janove Sehlin   +4 more
openaire   +3 more sources

Effect of pergolide treatment on insulin dysregulation in horses and ponies with pituitary pars intermedia dysfunction

Equine Veterinary Journal, Volume 57, Issue 6, Page 1612-1622, November 2025.
Abstract Background Due to the high frequency of laminitis reported for both conditions, the relationship between pituitary pars intermedia dysfunction (PPID) and insulin dysregulation (ID), and the potential role of dopamine in modifying insulin secretion, requires further investigation.
Nicolas C. Galinelli, Nicholas J. Bamford, Madison L. Erdody, Skye A. Mackenzie, Tobias Warnken, Patricia A. Harris, Martin N. Sillence, Simon R. Bailey   +7 more
wiley   +1 more source

Bromocriptine, a Dopamine (D2 ) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub–Therapeutic Doses to Ameliorate Hyperglycaemia [PDF]

Journal of Clinical and Diagnostic Research, 2013
Introduction: Bromocriptine, an ergot derivative, is an agonist at the dopamine 2 receptor and a sympatholytic. It is a well established drug in Parkinsonism, hyperprolactinaemia and acromegaly and it has various other clinical indications like ...
Harish Kumar V.S., Vinutha M.B., Pradeep A.N., Sathisha Aithal, Sindhura Reddy Baleed, Umakant N. Patil   +5 more
doaj   +1 more source

A peripartum cardiomyopathy case treated with bromocriptine

Turkish Journal of Internal Medicine, 2021
Introduction: Peripartum cardiomyopathy is a rare disease that is difficult to diagnose and treat. Clinical findings are similar with heart failure. New treatments are needed in addition to the treatment of heart failure.
Dilek Yeşilbursa, Şeyda Günay, Naile Bolca Topal, Osman Akın Serdar, Sümeyye Güllülü   +4 more
doaj   +1 more source

Multiple Biventricular Intracardiac Thrombi—An Unusual Finding in Peripartum Cardiomyopathy: A Case Report

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Peripartum cardiomyopathy (PPCM) is a rare form of heart failure occurring during late pregnancy or within 5 months postpartum, its etiology remaining elusive. While typically characterized by left ventricular dysfunction, it may present with intracardiac thrombi, raising the risk of systemic embolization.
Gidion Edwin, Yohana Mbishi, Baraka Alphonce, John Meda   +3 more
wiley   +1 more source

Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex [PDF]

, 2000
The role of dopamine D1 and D2 receptor subtypes in the regulation, in vivo, of the somatostatin (SRIF) receptor-effector system in rat frontoparietal cortex was investigated.
Arilla Ferreiro, Eduardo, Boyano Adánez, María del Carmen, Izquierdo Claros, Rosa María   +2 more
core   +2 more sources

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus

Journal of Diabetes Research, 2015
Background. Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control may reduce long-term CVD risk.
Citation Chamarthi, J. M. Bindu, Lawrence Gaziano, Aaron Blonde, Richard E Vinik, Michael Scranton, Dean Ezrokhi, Anthony H Rutty, C. Link, Bindu Chamarthi, J. Gaziano, R. Scranton, M. Ezrokhi, D. Rutty, A. Cincotta   +14 more
semanticscholar   +1 more source